| Customization: | Available |
|---|---|
| Packaging Material: | Foil Bag |
| Storage Method: | Frozen |
|
Still deciding? Get samples of US$ 530/kg
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
BI-G201 powder is composed of strains Bifidobacterium longum subsp. infantis BI-G201 and a special cryoprotectant agent. Bifidobacterium longum subsp. infantis is the most important microorganism found in the large intestine of infants and has been validated as an effective adjunct therapy in the treatment of acute diarrhea. Bacteriocidal activity has also been observed against such pathogens as Clostridia, Salmonella, and Shigella. Bifidobacterium longum subsp. infantis has been shown to stimulate the production of immunomodulating agents. It is also powerful in prevention and remission of acute diarrhea & antibiotics-associated diarrhea, irritable bowel syndrome remission etc.
Kingdom: Bacteria
Division: Firmicutes
Class: Actinobacteria
Family: Bifidobacteriaceae
Genus: Bifidobacterium
Species: Bifidobacterium longum
Sub-species: Bifidobacterium longum subsp.infantis
Bifidobacterium longum subsp. Infantis (B.infantis), is a gram-positive, catalase-negative, rod-shaped bacteriumpresent in the human gastrointestinal tract. It is a micro-aerotolerant anaerobe and considered to be one of the earliest colonizers of the gastrointestinal tract of infants. While Bifidobacterium longum (include B.longum and B.infantis) is not significantly present in the adult gastrointestinal tract, it is considered part of the gut flora andits production of lactic acid is believed to prevent growth of pathogenic organisms. Bifidobacterium longum isnon-pathogenic and is often added to food products for its beneficial probiotic health effects.
Bifidobacterium longum colonizes the human gastrointestinal tract where it, along other Bifidobacterium, represents up to 90% of the bacteria of an infant's GI tract. This number gradually drops to 3% in an adult's GI tract as other enteric bacteria such as Bacteroides and Eubacterium begintodominate. The persistence of Bifidobacterium longum in the gut is attributed to the glycoprotein-bindingfimbriae structures and bacterial polysaccharides, the latter of which possess strong electrostatic charges thataid in the adhesion of Bifidobacterium longum to intestinal endothelial cells. This adhesion is also enhanced bythe fatty acids in the lipoteichoic acid of the Bifidobacterium longum cell wall.
){kind=link}